Skip to main content
. 2022 Feb 3;8:799497. doi: 10.3389/fmolb.2021.799497

FIGURE 6.

FIGURE 6

PAFAH1B3 Is Correlated With Clinical Characteristics and Prognosis in NSCLC. (A) The expression of PAFAH1B3 in NSCLC. (B) The correlation between PAFAH1B3 expression and Clinical Characteristics in NSCLC, including the pathologic stage, TNM stage, residual tumor, and primary therapy outcome. (C) The prognosis of PAFAH1B3 in NSCLC.